{
  "bio": [
    "Zhu Yi chairs Sichuan Biokin Pharmaceutical, a China supplier of cancer drugs and other pharmaceutical products.",
    "Biokin went public on the Shanghai Stock Exchange in January 2023.",
    "Biokin operates in the U.S. through a Redmond, Washington-based subsidiary, Systimmune.",
    "He taught immunology and microbiology at West China Medical University from 1987 to 1990.",
    "Zhu has a master's in biology from Fudan University and a doctorate in management from Sichuan University."
  ],
  "about": []
}